Immunoreactivity to ubiquitin-protein conjugates is present early in the disease process in the brains of scrapie-infected mice

J. Lowe, J. Fergusson, N. Kenward, L. László, M. Landon, C. Farquhar, J. Brown, J. Hope, R. J. Mayer

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Brains from mice infected with either the 87V or the ME7 strains of mouse-passaged sheep scrapie were taken at stages during the disease process and immunostained to show the localization of ubiquitin-protein conjugates. In both models, conjugates were seen as fine, dot-like structures; as coarser, granular lesions within or adjacent to neurones; and in areas surrounding plaques. The dot-like structures were visible at 28 days post-ME7 infection and at 55 days in 87V infected mice. In both models, the extent of immunoreactive changes increased as the disease progressed and terminal infection was as described earlier by us (Lowe et al., J. Pathol 1990; 162: 61-66). The patterns of development of these features were distinctive in two ways: progression from region to region was observable and the density of the pathological lesions grew exponentially as the clinical symptoms appeared. The earliest pathological dot-like structures corresponded temporally with the earliest detection of PrP(SC) by Western blotting, and immunogold electron microscopic investigation of the dot-like lesions indicated that they were the multi-vesicular, lysosome-related, dense bodies that we have described previously in terminal disease (Laszlo et al., J Pathol 1992; 166: 333-341). Until now, ubiquitin-protein conjugates were seen mainly in inclusion bodies associated with the terminal stages of a range of human degenerative diseases. This study establishes that ubiquitin-protein conjugates accumulate in lysosome-related bodies very early and appear to be intimately related to the pathological processes in the animal disorders that we have studied.

Original languageEnglish
Pages (from-to)169-177
Number of pages9
JournalJournal of Pathology
Volume168
Issue number2
DOIs
Publication statusPublished - 1992

Fingerprint

Scrapie
Ubiquitin
Brain
Lysosomes
Proteins
Inclusion Bodies
Pathologic Processes
Infection
Sheep
Western Blotting
Electrons
Neurons

Keywords

  • amyloid plaque
  • murine scrapie
  • neurodegeneration
  • prion disease
  • prion protein
  • ubiquitin

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Immunoreactivity to ubiquitin-protein conjugates is present early in the disease process in the brains of scrapie-infected mice. / Lowe, J.; Fergusson, J.; Kenward, N.; László, L.; Landon, M.; Farquhar, C.; Brown, J.; Hope, J.; Mayer, R. J.

In: Journal of Pathology, Vol. 168, No. 2, 1992, p. 169-177.

Research output: Contribution to journalArticle

Lowe, J. ; Fergusson, J. ; Kenward, N. ; László, L. ; Landon, M. ; Farquhar, C. ; Brown, J. ; Hope, J. ; Mayer, R. J. / Immunoreactivity to ubiquitin-protein conjugates is present early in the disease process in the brains of scrapie-infected mice. In: Journal of Pathology. 1992 ; Vol. 168, No. 2. pp. 169-177.
@article{7532d57f39e84ab9831973a1b136acce,
title = "Immunoreactivity to ubiquitin-protein conjugates is present early in the disease process in the brains of scrapie-infected mice",
abstract = "Brains from mice infected with either the 87V or the ME7 strains of mouse-passaged sheep scrapie were taken at stages during the disease process and immunostained to show the localization of ubiquitin-protein conjugates. In both models, conjugates were seen as fine, dot-like structures; as coarser, granular lesions within or adjacent to neurones; and in areas surrounding plaques. The dot-like structures were visible at 28 days post-ME7 infection and at 55 days in 87V infected mice. In both models, the extent of immunoreactive changes increased as the disease progressed and terminal infection was as described earlier by us (Lowe et al., J. Pathol 1990; 162: 61-66). The patterns of development of these features were distinctive in two ways: progression from region to region was observable and the density of the pathological lesions grew exponentially as the clinical symptoms appeared. The earliest pathological dot-like structures corresponded temporally with the earliest detection of PrP(SC) by Western blotting, and immunogold electron microscopic investigation of the dot-like lesions indicated that they were the multi-vesicular, lysosome-related, dense bodies that we have described previously in terminal disease (Laszlo et al., J Pathol 1992; 166: 333-341). Until now, ubiquitin-protein conjugates were seen mainly in inclusion bodies associated with the terminal stages of a range of human degenerative diseases. This study establishes that ubiquitin-protein conjugates accumulate in lysosome-related bodies very early and appear to be intimately related to the pathological processes in the animal disorders that we have studied.",
keywords = "amyloid plaque, murine scrapie, neurodegeneration, prion disease, prion protein, ubiquitin",
author = "J. Lowe and J. Fergusson and N. Kenward and L. L{\'a}szl{\'o} and M. Landon and C. Farquhar and J. Brown and J. Hope and Mayer, {R. J.}",
year = "1992",
doi = "10.1002/path.1711680204",
language = "English",
volume = "168",
pages = "169--177",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Immunoreactivity to ubiquitin-protein conjugates is present early in the disease process in the brains of scrapie-infected mice

AU - Lowe, J.

AU - Fergusson, J.

AU - Kenward, N.

AU - László, L.

AU - Landon, M.

AU - Farquhar, C.

AU - Brown, J.

AU - Hope, J.

AU - Mayer, R. J.

PY - 1992

Y1 - 1992

N2 - Brains from mice infected with either the 87V or the ME7 strains of mouse-passaged sheep scrapie were taken at stages during the disease process and immunostained to show the localization of ubiquitin-protein conjugates. In both models, conjugates were seen as fine, dot-like structures; as coarser, granular lesions within or adjacent to neurones; and in areas surrounding plaques. The dot-like structures were visible at 28 days post-ME7 infection and at 55 days in 87V infected mice. In both models, the extent of immunoreactive changes increased as the disease progressed and terminal infection was as described earlier by us (Lowe et al., J. Pathol 1990; 162: 61-66). The patterns of development of these features were distinctive in two ways: progression from region to region was observable and the density of the pathological lesions grew exponentially as the clinical symptoms appeared. The earliest pathological dot-like structures corresponded temporally with the earliest detection of PrP(SC) by Western blotting, and immunogold electron microscopic investigation of the dot-like lesions indicated that they were the multi-vesicular, lysosome-related, dense bodies that we have described previously in terminal disease (Laszlo et al., J Pathol 1992; 166: 333-341). Until now, ubiquitin-protein conjugates were seen mainly in inclusion bodies associated with the terminal stages of a range of human degenerative diseases. This study establishes that ubiquitin-protein conjugates accumulate in lysosome-related bodies very early and appear to be intimately related to the pathological processes in the animal disorders that we have studied.

AB - Brains from mice infected with either the 87V or the ME7 strains of mouse-passaged sheep scrapie were taken at stages during the disease process and immunostained to show the localization of ubiquitin-protein conjugates. In both models, conjugates were seen as fine, dot-like structures; as coarser, granular lesions within or adjacent to neurones; and in areas surrounding plaques. The dot-like structures were visible at 28 days post-ME7 infection and at 55 days in 87V infected mice. In both models, the extent of immunoreactive changes increased as the disease progressed and terminal infection was as described earlier by us (Lowe et al., J. Pathol 1990; 162: 61-66). The patterns of development of these features were distinctive in two ways: progression from region to region was observable and the density of the pathological lesions grew exponentially as the clinical symptoms appeared. The earliest pathological dot-like structures corresponded temporally with the earliest detection of PrP(SC) by Western blotting, and immunogold electron microscopic investigation of the dot-like lesions indicated that they were the multi-vesicular, lysosome-related, dense bodies that we have described previously in terminal disease (Laszlo et al., J Pathol 1992; 166: 333-341). Until now, ubiquitin-protein conjugates were seen mainly in inclusion bodies associated with the terminal stages of a range of human degenerative diseases. This study establishes that ubiquitin-protein conjugates accumulate in lysosome-related bodies very early and appear to be intimately related to the pathological processes in the animal disorders that we have studied.

KW - amyloid plaque

KW - murine scrapie

KW - neurodegeneration

KW - prion disease

KW - prion protein

KW - ubiquitin

UR - http://www.scopus.com/inward/record.url?scp=0026452020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026452020&partnerID=8YFLogxK

U2 - 10.1002/path.1711680204

DO - 10.1002/path.1711680204

M3 - Article

VL - 168

SP - 169

EP - 177

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 2

ER -